Equities

Kose Corp

Kose Corp

Actions
Consumer DiscretionaryPersonal Goods
  • Price (JPY)8,048.00
  • Today's Change68.00 / 0.85%
  • Shares traded213.90k
  • 1 Year change-30.77%
  • Beta0.4285
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

KOSE Corporation is a Japan-based company principally engaged in the manufacture and sale of cosmetic products. The Company operates in two business segments. Make-up segment is engaged in the manufacture and sale of products under the brands of KOSE, Sekkisei, ESPRIQUE, COSME DECORTE, Predia, INFINITY, JILLSTUART, ADDICTION, CLIE, ALBION, tarte, among others. Cosmetry segment is engaged in the manufacture and sale of products under the brands of Visee, Fasio, ELSIA, softymo, SUNCUT, CLEAR TURN, Stephen Knoll New York, Nature & Co, among others. The Company is also involved in the manufacture and sale of amenity products, the leasing of real estate properties, the manufacture and export of materials, as well as the original equipment manufacturing (OEM) business.

  • Revenue in JPY (TTM)315.24bn
  • Net income in JPY14.58bn
  • Incorporated1948
  • Employees7.56k
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Milbon Co Ltd49.59bn4.09bn99.95bn1.14k24.042.0615.672.02125.56125.561,523.591,467.690.8971.829.9643,495,830.007.3910.078.6211.7561.4564.698.2411.332.29--0.0049.235.586.30-28.25-2.3019.1310.26
Earth Corp165.11bn4.71bn116.60bn4.79k24.681.6012.210.7062212.73212.737,463.123,286.451.083.154.2734,484,130.003.333.866.977.7440.0039.753.072.540.8808--0.082757.963.94-2.65-22.65--22.660.5164
Arata Corp954.51bn10.57bn126.38bn2.89k11.271.068.290.1324310.96310.9628,063.403,295.323.0820.367.42329,939,200.003.413.197.576.889.849.971.110.99371.15123.930.245625.185.894.5925.538.3811.6718.25
Noevir Holdings Co Ltd63.91bn7.47bn182.74bn1.37k24.473.6221.092.86218.64218.641,871.041,476.180.84882.456.4646,716,380.0010.098.7211.919.8867.3166.0611.8912.213.69--0.0164103.982.301.581.11-0.4348-4.224.10
Pigeon Corp97.77bn6.43bn190.02bn3.62k29.052.2916.411.9453.7853.78817.56683.020.9163.235.1527,023,770.006.1610.057.5512.4348.2548.796.729.953.45--0.0093.82-0.4846-2.05-13.49-12.210.94672.25
PALTAC Corp1.16tn21.19bn272.29bn2.24k12.820.96859.820.2345337.16337.1618,479.424,462.722.3819.925.25519,160,000.004.344.697.508.397.497.681.821.941.43--0.0023.994.332.567.200.8661-10.836.69
Pola Orbis Holdings Inc171.30bn9.76bn333.85bn4.05k33.061.9318.671.9544.0744.07773.43755.160.84171.8810.5242,339,100.004.825.375.566.1881.8482.845.736.273.21--0.0003124.314.21-6.96-15.562.8712.16-8.25
Fancl Corp109.77bn8.32bn365.64bn1.28k40.944.2329.733.3368.5168.51904.24663.011.082.989.1186,027,430.008.207.9810.409.6366.9968.587.587.002.82--0.0052.357.03-1.9777.730.4219-7.932.53
Kobayashi Pharmaceutical Co Ltd172.97bn13.91bn443.32bn3.53k30.852.0121.082.56184.09184.092,307.552,821.320.65422.674.7448,943,410.005.268.016.4110.1854.7256.458.0412.242.21--0.005433.194.330.70371.582.4529.678.88
Lion Corp408.51bn20.26bn446.84bn7.55k21.811.5210.311.0972.0272.021,451.451,032.180.85843.765.8154,107,680.004.795.637.048.9345.3047.605.596.451.20--0.096331.013.312.88-33.34-10.609.215.39
Kose Corp315.24bn14.58bn487.65bn7.56k31.501.6518.601.55255.46255.465,524.984,892.200.84821.227.2441,709,980.004.24--5.41--69.99--5.00--2.78--0.0358--3.90---37.87------
Shiseido Co Ltd987.39bn10.01bn1.37tn30.54k136.392.0715.421.3825.0325.032,469.581,653.130.75391.596.1732,330,880.000.91332.911.344.3975.0673.511.213.520.7494--0.316275.17-8.84-2.33-36.41-18.75-10.635.92
Data as of Sep 20 2024. Currency figures normalised to Kose Corp's reporting currency: Japanese Yen JPY

Institutional shareholders

14.81%Per cent of shares held by top holders
HolderShares% Held
MFS International Singapore Pte Ltd.as of 31 Jul 20242.04m3.37%
Nomura Asset Management Co., Ltd.as of 30 Aug 20241.26m2.08%
The Vanguard Group, Inc.as of 04 Sep 20241.15m1.90%
MFS International (UK) Ltd.as of 31 Aug 20241.12m1.84%
Capital Research & Management Co. (World Investors)as of 30 Jun 2024900.30k1.49%
Nikko Asset Management Co., Ltd.as of 06 Sep 2024593.20k0.98%
Daiwa Asset Management Co. Ltd.as of 30 Aug 2024576.40k0.95%
Baillie Gifford & Co.as of 31 Aug 2024541.70k0.89%
BlackRock Fund Advisorsas of 05 Sep 2024409.80k0.68%
Norges Bank Investment Managementas of 31 Dec 2023385.61k0.64%
More ▼
Data from 30 Jun 2024 - 31 Aug 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.